Association of proton pump inhibitors with the risk of hepatic encephalopathy during hospitalization for liver cirrhosis
Open accessAbstract
Background: Hepatic encephalopathy is associated with altered gut microbiota. Proton pump inhibitors increase the risk of small bowel bacterial overgrowth. Objectives: This was a case‐control study aimed at exploring the relationship of proton pump inhibitor use with the risk of hepatic encephalopathy during hospitalization in liver cirrhosis. Methods: Case and control groups were defined as cirrhotic patients who developed hepatic encephalopathy during hospitalization and those without hepatic encephalopathy at admission or during hospitalization, respectively. Age, gender, and Child‐Pugh score were matched between the groups. Odds ratios with 95% confidence intervals were calculated to express the association of proton pump inhibitors with the risk of hepatic encephalopathy. Four subgroup analyses were performed after excluding patients with acute upper gastrointestinal bleeding, infections, and in‐hospital death, and after matching model for end‐stage liver disease score. Results: In the overall analysis, 128 patients were included in each group of cases and controls. The proportion of proton pump inhibitor use was significantly higher in the case group than the control group (79.7% vs 43%, p < 0.001). Proton pump inhibitor use (odds ratio = 3.481, 95% confidence interval: 1.651–7.340, p = 0.001) was independently associated with the development of hepatic encephalopathy in the multivariate analysis. In the four subgroup analyses, proton pump inhibitor use remained independently associated with the risk of hepatic encephalopathy. Conclusion: Proton pump inhibitor use might increase the risk of hepatic encephalopathy during hospitalization.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
PPI-induced dysbiosis may represent a risk factor for hepatic encephalopathy (HE) and spontaneous bacterial peritonitis (SBP) in cirrhotic patients.
“PPI-induced dysbiosis may represent a risk factor for hepatic encephalopathy (HE) and spontaneous bacterial peritonitis (SBP) in cirrhotic patients[88-90].”
From Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified (2019) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Vilstrup, H., Amodio, P., Bajaj, J. S., Córdoba, J., Ferenci, P., Mullen, K. D., Weißenborn, K., & Wong, P. Y. N. (2014) · Hepatology · doi:10.1002/hep.27210 · Cited by 2,065 · see citing works
(2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.004 · Cited by 1,726 · see citing works
Proton pump inhibitors affect the gut microbiome
Imhann, F., Bonder, M. J., Vich Vila, A., Fu, J., Mujagic, Z., Vork, L., Tigchelaar, E. F., Jankipersadsing, S. A., Cenit, M. C., Harmsen, H. J. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310376 · Cited by 1,371 · see citing works
Altered profile of human gut microbiome is associated with cirrhosis and its complications
Bajaj, J. S., Heuman, D. M., Hylemon, P. B., Sanyal, A. J., White, M. B., Monteith, P., Noble, N. A., Unser, A. B., Daita, K., Fisher, A. R., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.019 · Cited by 1,099 · see citing works
Child–Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis
Peng, Y., Qi, X., & Guo, X. (2016) · Medicine · doi:10.1097/md.0000000000002877 · Cited by 477 · see citing works
Self-citationValue of the critical flicker frequency in patients with minimal hepatic encephalopathy†
Romero‐Gómez, M., Córdoba, J., Jover, R., del Olmo, J. A., Ramirez, M. C., Rey, R., de‐Madaria, E., Montoliu, C., Nuñez, D., Flavià, M., et al. (2007) · Hepatology · doi:10.1002/hep.21586 · Cited by 323 · see citing works
Córdoba, J., Cots, M. V., Simón‐Talero, M., Amorós, À., Pavesi, M., Vilstrup, H., Angeli, P., Domenicali, M., Ginès, P., Bernardi, M., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.10.004 · Cited by 315 · see citing works
Gupta, A., Dhiman, R. K., Kumari, S., Rana, S., Agarwal, R., Duseja, A., & Chawla, Y. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.017 · Cited by 202 · see citing works
Pantoprazole reduces the size of postbanding ulcers after variceal band ligation
Shaheen, N. J., Stuart, E., Schmitz, S. M., Mitchell, K. L., Fried, M. W., Zacks, S., Russo, M. W., Galanko, J., & Shrestha, R. (2005) · Hepatology · doi:10.1002/hep.20593 · Cited by 198 · see citing works
Shukla, S., Shukla, A. K., Mehboob, S., & Guha, S. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04574.x · Cited by 197 · see citing works
Critical flicker frequency: Diagnostic tool for minimal hepatic encephalopathy
Sharma, P., Sharma, B. C., Puri, V., & Sarin, S. K. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.02.022 · Cited by 194 · see citing works
Dam, G., Vilstrup, H., Watson, H., & Jepsen, P. (2016) · Hepatology · doi:10.1002/hep.28737 · Cited by 190 · see citing works
Tsai, C.-F., Chen, M., Wang, Y., Chu, C., Huang, Y., Lin, H., Hou, M., Lee, F., Su, T., & Lu, C. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.09.007 · Cited by 175 · see citing works
Bajaj, J. S., Ananthakrishnan, A. N., Hafeezullah, M., Zadvornova, Y., Dye, A., McGinley, E. L., Saeian, K., Heuman, D. M., Sanyal, A. J., & Hoffmann, R. G. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.615 · Cited by 174 · see citing works
Small‐intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease
PANDE, C., KUMAR, A., & SARIN, S. K. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.03994.x · Cited by 152 · see citing works
Deshpande, A., Pasupuleti, V., Thota, P., Pant, C., Mapara, S. M., Hassan, S., Rolston, D. D. K., Sferra, T. J., & Hernández, A. V. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12065 · Cited by 149 · see citing works
Bajaj, J. S., Cox, I. J., Betrapally, N. S., Heuman, D. M., Schubert, M. L., Ratneswaran, M., Hylemon, P. B., White, M. B., Daita, K., Noble, N. A., et al. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00268.2014 · Cited by 143 · see citing works
Richardson, A. J., McKain, N., & Wallace, R. J. (2013) · BMC Microbiology · doi:10.1186/1471-2180-13-6 · Cited by 134 · see citing works
Balata, S., Damink, S. W. M. O., Ferguson, K. J., Marshall, I., Hayes, P. C., Deutz, N. E. P., Williams, R. L., Wardlaw, J. M., & Jalan, R. (2003) · Hepatology · doi:10.1053/jhep.2003.50156 · Cited by 114 · see citing works
Ammonia and Its Role in the Pathogenesis of Hepatic Encephalopathy
Parekh, P. J., & Balart, L. A. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.05.002 · Cited by 87 · see citing works
Cichoż‐Lach, H. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i1.26 · Cited by 82 · see citing works
Zou, D., Qi, X., Zhu, C.-H., Zheng, N., Hou, F., Zhao, J., Peng, Y., Li, J., Deng, H., & Guo, X. (2016) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2016.15502 · Cited by 80 · see citing works
Self-citationPeng, Y., Qi, X., Dai, J., Li, H., & Guo, X. (2015) · PubMed Central · Cited by 78 · see citing works
Self-citationPatterns of proton pump inhibitor use in clinical practice
Barrison, A. F., Jarboe, L. A., Weinberg, B. M., Nimmagadda, K., SULLIVAN, L. M., & Wolfe, M. M. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00901-9 · Cited by 77 · see citing works
Use and overuse of proton pump inhibitors in cirrhotic patients.
Chávez-Tapia, N. C., Téllez-Ávila, F. I., García-Leiva, J., & Valdovinos, M. A. (2008) · PubMed · Cited by 60 · see citing works
Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability
van Vlerken, L. G., Huisman, E. J., van Hoek, B., Renooij, W., de Rooij, F. W. M., Siersema, P. D., & van Erpecum, K. J. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02643.x · Cited by 53 · see citing works
Al‐Osaimi, A. M. S., & Bleibel, W. (2012) · Saudi Journal of Gastroenterology · doi:10.4103/1319-3767.101123 · Cited by 41 · see citing works
Cadranel, J., Denis, J., Pauwels, A., Barbare, J., Eugène, C., Martino, V. D., Poquet, E. G., Medini, A., Coutarel, P., Latrive, J., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80038-5 · Cited by 32 · see citing works
Qi, X., Li, H., Chen, J., Xia, C., Peng, Y., Dai, J., Hou, Y., Deng, H., Li, J., & Guo, X. (2015) · Gastroenterology Research and Practice · doi:10.1155/2015/274534 · Cited by 27 · see citing works
Self-citationBeziz, D., Colas, S., Collin, C., Dray‐Spira, R., & Zureik, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155783 · Cited by 23 · see citing works
Lin, Z.-N., Zuo, Y.-Q., & Hu, P. (2014) · Hepatitis Monthly · doi:10.5812/hepatmon.16258 · Cited by 17 · see citing works
Khan, M. A., Cholankeril, G. T., & Howden, C. W. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.10.050 · Cited by 10 · see citing works
Proton pump inhibitors and hepatic encephalopathy: fly quiet in the eye of the storm
Picardi, A., & Gentilucci, U. V. (2017) · AME Medical Journal · doi:10.21037/amj.2017.04.07 · Cited by 1 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Sharma P, Sharma BC, Puri V, et al. Critical flicker fre- quency: Diagnostic tool for minimal hepatic encephalop- athy. J Hepatol 2007; 47: 67-73.
Cited by
Sorted by citations
Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified
Bruno, G., Zaccari, P., Rocco, G., Scalese, G., Panetta, C., Porowska, B., Pontone, S., & Severi, C. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i22.2706 · Cited by 258 · see citing works
Hepatic Encephalopathy: Current and Emerging Treatment Modalities
Fallahzadeh, M. A., & Rahimi, R. S. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.04.034 · Cited by 43 · see citing works
Ma, Y.-J., Cao, Z., Li, Y., & Feng, S. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i21.2675 · Cited by 33 · see citing works
Xu, W., Bai, Z., Shang, Y., Wang, J., Wong, Y. J., & Qi, X. (2023) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848231167858 · Cited by 32 · see citing works
Self-citationTantai, X., Yang, L., Wei, Z., Xiao, C., Chen, L., Wang, J., & Liu, N. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i21.2683 · Cited by 29 · see citing works
Characteristics of peptic ulcer bleeding in cirrhotic patients with esophageal and gastric varices
Lu, Z., Sun, X., Han, J., Jin, B., Zhang, W., Han, J., Ma, X., Liu, B., Yu, X., Wu, Q., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-76530-3 · Cited by 21 · see citing works
Hepatic Encephalopathy and Nutrition Influences: A Narrative Review
Fallahzadeh, M. A., & Rahimi, R. S. (2019) · Nutrition in Clinical Practice · doi:10.1002/ncp.10458 · Cited by 20 · see citing works
Implications of the Liver-Gut Axis in Liver Disease: From Mechanisms to Therapeutic Targets
Ramírez-Mejía, M. M., Ponciano‐Rodríguez, G., & Méndez‐Sánchez, N. (2025) · Archives of Medical Research · doi:10.1016/j.arcmed.2025.103335 · Cited by 15 · see citing works
Dai, R., Sag, A. A., Martin, J. G., Befera, N. T., Pabon‐Ramos, W. M., Suhocki, P. V., Smith, T. P., Kim, C., Muir, A. J., & Ronald, J. (2021) · Clinical Imaging · doi:10.1016/j.clinimag.2021.04.034 · Cited by 13 · see citing works
Shi, D., Zhou, Z., Dai, Y., Pan, X., & Cao, Q. (2019) · Clinical Drug Investigation · doi:10.1007/s40261-019-00810-8 · Cited by 13 · see citing works
Yoon, J. S., Hong, J. H., Park, S. Y., Kim, S. U., Kim, H. Y., Kim, J. Y., Hur, M. H., Park, M. K., Lee, Y. B., Lee, H. A., et al. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17909 · Cited by 10 · see citing works
Kuo, C., Lin, C.-Y., Chen, C.-W., Hsu, C.-Y., Hsieh, S., Chiu, C., & Lin, W. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11111063 · Cited by 10 · see citing works
Effect of a Proton Pump Inhibitor on the Duodenum Microbiome of Gastric Ulcer Patients
Lim, J.-H., Shin, J., & Park, J. (2022) · Life · doi:10.3390/life12101505 · Cited by 9 · see citing works
Kuan, Y., Huang, K.-W., Lin, C., Luo, J., & Kao, C. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081108 · Cited by 8 · see citing works
양성자펌프억제제와 간경화 합병증의 연관성: 체계적 고찰 및 메타 분석
황성준 (2019) · Seoul National University Open Repository (Seoul National University) · Cited by 8 · see citing works
Maggi, D. C., Borgonovo, A., Bansho, E. T. O., Silva, P. E. S. E., Silva, T. E., Colombo, B. S., Wildner, L. M., Bazzo, M. L., Dantas-Corrêa, E. B., Narciso-Schiavon, J. L., et al. (2019) · Annals of Hepatology · doi:10.1016/j.aohep.2018.11.002 · Cited by 7 · see citing works
Sakamaki, A., Kamimura, K., Yokoo, T., Osaki, A., Yoshikawa, S., Arao, Y., Setsu, T., Kamimura, H., Waguri, N., Takeuchi, M., et al. (2021) · Medicine · doi:10.1097/md.0000000000026902 · Cited by 6 · see citing works
Proton Pump Inhibitors in Patients with Cirrhosis: Pharmacokinetics, Benefits and Drawbacks
El-Azab, G. (2024) · Current Gastroenterology Reports · doi:10.1007/s11894-024-00943-7 · Cited by 5 · see citing works
The impact of proton pump inhibitors in liver diseases and the effects on the liver
Liu, Y., & Chen, M. K. (2022) · Journal of Digestive Diseases · doi:10.1111/1751-2980.13093 · Cited by 5 · see citing works
Chen, X., Zhou, T., Zhou, T., Li, Y., Sun, X., Cheng, B., Zhong, N., Lu, X., & Gao, Y. (2023) · Portal hypertension & cirrhosis · doi:10.1002/poh2.37 · Cited by 3 · see citing works
Zhang, P., Zhou, L., Chen, L., Zhang, Z., Han, R., Guo, G., & Zhou, H. (2022) · Biomedicines · doi:10.3390/biomedicines10123040 · Cited by 3 · see citing works
Inhibitory pompy protonowej w opiece paliatywnej
Zaporowska-Stachowiak, I., & Oduah, M.-T. A. (2019) · Palliative Medicine in Practice · doi:10.5603/pmpi.2019.0013 · Cited by 2 · see citing works
Henkel, S. A. F., Vetterly, C. G., Squires, R. H., McKiernan, P. J., & Squires, J. E. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1825685 · Cited by 2 · see citing works
Chinese Consensus on Clinical Diagnosis and Management of Covert Hepatic Encephalopathy
Chinese Society of Gastroenterology, C. M. A. (2025) · Journal of Digestive Diseases · doi:10.1111/1751-2980.70005 · Cited by 1 · see citing works
Gao, F., Méndez‐Sánchez, N., & Qi, X. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.08.07 · Cited by 1 · see citing works
Self-citationYao, H., Li, H., Ma, Z., Wu, Y., Tang, Y., Meng, H., Yu, H., Peng, C., Teng, Y., Zhang, Q., et al. (2022) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848221104365 · Cited by 1 · see citing works
Self-citationCharacteristics of peptic ulcer bleeding in cirrhosis with esophageal and gastric varicesPreprint
Lu, Z., Sun, X., Han, J., Jin, B. K., Zhang, W., Wang, Y., Han, J., Ma, X., Liu, B., Yu, X., et al. (2019) · doi:10.21203/rs.2.12787/v1 · Cited by 1 · see citing works
Balafar, M., Ghojazadeh, M., Shahsavarinia, K., Parsian, Z., Hamedani, S., & Soleimanpour, H. (2023) · Hepatitis Monthly · doi:10.5812/hepatmon-132642
- Authors
- Zhu, J., Qi, X., Yu, H., Yoshida, E. M., Mendez-Sanchez, N., Zhang, X., Wang, R., Deng, H., Li, J., Han, D., & Guo, X.
- Affiliations
- Shenyang Pharmaceutical University (CN)
- General Hospital of Shenyang Military Region (CN)
- Vancouver General Hospital (CA)
- Liver Research Unit Medica Sur Clinic & Foundation Mexico City Mexico
- Corresponding author
- Qi, Xingshun
- ORCID
- Venue
- United European Gastroenterology Journal
- Publisher
- Wiley
- Published
- 2018-10
- Volume
- 6
- Issue
- 8
- Pages
- 1179-1187
- ISSN
- 2050-6406 (ISSN-L)
- 2050-6414
- PMC
- PMC6169047
- OpenAlex
- W2801918952
- Cited by
- 28
- References
- 34
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 3 · 2020: 2 · 2019: 10 · 2018: 1
- FWCI
- 2.50
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- United European Gastroenterology Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal Bleeding Diagnosis and Treatment
- Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
- Keywords
- proton pump inhibitors, hepatic encephalopathy, liver cirrhosis, small intestinal bacterial overgrowth, gut microbiota, hospitalization, drug safety, Child-Pugh score, MELD score
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
